These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17635174)

  • 1. Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections.
    Roblot F; Besnier JM; Giraudeau B; Simonnard N; Jonville-Bera AP; Coipeau P; Choutet P; Autret-Leca E; Le Guellec C
    Fundam Clin Pharmacol; 2007 Aug; 21(4):363-9. PubMed ID: 17635174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
    Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
    Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
    Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
    Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.
    Bernard A; Kermarrec G; Parize P; Caruba T; Bouvet A; Mainardi JL; Sabatier B; Nich C
    J Infect; 2015 Aug; 71(2):200-6. PubMed ID: 25936632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
    Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of rifampicin in dogs and serum alanine aminotransferase monitoring recommendations based on a retrospective study of 344 dogs.
    Bajwa J; Charach M; Duclos D
    Vet Dermatol; 2013 Dec; 24(6):570-5, e135-6. PubMed ID: 24164464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.
    Nijland HM; L'homme RF; Rongen GA; van Uden P; van Crevel R; Boeree MJ; Aarnoutse RE; Koopmans PP; Burger DM
    AIDS; 2008 May; 22(8):931-5. PubMed ID: 18453852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.
    Friedland G; Khoo S; Jack C; Lalloo U
    J Antimicrob Chemother; 2006 Dec; 58(6):1299-302. PubMed ID: 17032686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.
    Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2006 Oct; 28(5):654-61. PubMed ID: 17038881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
    Harbarth S; von Dach E; Pagani L; Macedo-Vinas M; Huttner B; Olearo F; Emonet S; Uçkay I
    J Antimicrob Chemother; 2015 Jan; 70(1):264-72. PubMed ID: 25209610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
    Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E
    Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections.
    Schindler M; Bernard L; Belaieff W; Gamulin A; Racloz G; Emonet S; Lew D; Hoffmeyer P; Uçkay I
    J Infect; 2013 Nov; 67(5):433-8. PubMed ID: 23850617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
    Karabay O; Sencan I; Kayas D; Sahin I
    BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial.
    Watt G; Kantipong P; Jongsakul K; Watcharapichat P; Phulsuksombati D; Strickman D
    Lancet; 2000 Sep; 356(9235):1057-61. PubMed ID: 11009140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.
    Avihingsanon A; van der Lugt J; Singphore U; Gorowara M; Boyd M; Ananworanich J; Phanuphak P; Burger D; Ruxrungtham K
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1170-6. PubMed ID: 22250979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.
    Czekaj J; Dinh A; Moldovan A; Vaudaux P; Gras G; Hoffmeyer P; Lew D; Bernard L; Uçkay I
    Scand J Infect Dis; 2011 Dec; 43(11-12):962-7. PubMed ID: 21916775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. 2. Drug resistance, drug concentration in blood and side effects].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Dec; 46(12):481-9. PubMed ID: 5004601
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
    Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
    Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.